Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Eagle Pharma and Teva prevail in Bendeka patent challenge
01:08pm, Tuesday, 28'th Apr 2020
Eagle Pharmaceuticals (NASDAQ:EGRX) and licensee Teva Pharmaceutical Industries (NYSE:TEVA) announce a favorable outcome in a patent dispute from would-be generic competitors to blood cancer med Bende
Delaware court issues patent decision if favor of Eagle Pharma and Teva EGRX;TEVA
11:15am, Tuesday, 28'th Apr 2020
Delaware court issues patent decision if favor of Eagle Pharma and Teva EGRX TEVA
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") and Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) ("Teva") announced today that on April 27, 2020, the U.S. District Court fo
Eagle Pharmaceuticals (NASDAQ:EGRX) Upgraded at BidaskClub
08:44am, Tuesday, 28'th Apr 2020
Eagle Pharmaceuticals (NASDAQ:EGRX) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research note issued on Tuesday, BidAskClub reports. A number of other equities anal
Earnings Preview: Eagle Pharmaceuticals (EGRX) Q1 Earnings Expected to Decline
12:00am, Tuesday, 28'th Apr 2020Nuveen Asset Management LLC Has $2.60 Million Stock Holdings in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:56am, Monday, 27'th Apr 2020
Nuveen Asset Management LLC cut its position in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange C
Eagle Pharmaceuticals Inc to Post Q1 2020 Earnings of $0.30 Per Share, William Blair Forecasts (NASDAQ:EGRX)
05:32am, Saturday, 25'th Apr 2020
Eagle Pharmaceuticals Inc (NASDAQ:EGRX) – Investment analysts at William Blair decreased their Q1 2020 EPS estimates for Eagle Pharmaceuticals in a research note issued to investors on Tuesday, Apri
Is Eagle Pharmaceuticals, Inc.’s (NASDAQ:EGRX) CEO Salary Justified?
11:45am, Friday, 24'th Apr 2020
In 2007, Scott Tarriff was appointed CEO of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX). First, this article will...
$47.76 Million in Sales Expected for Eagle Pharmaceuticals Inc (NASDAQ:EGRX) This Quarter
07:10am, Friday, 24'th Apr 2020
Wall Street brokerages expect Eagle Pharmaceuticals Inc (NASDAQ:EGRX) to announce $47.76 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have prov
Analysts' Top Healthcare Picks: Eagle Pharmaceuticals (EGRX), Biogen (BIIB)
02:41pm, Thursday, 23'rd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eagle Pharmaceuticals (EGRX) and Biogen (BIIB) with bullish
Cantor Fitzgerald Reiterates "Hold" Rating for Eagle Pharmaceuticals (NASDAQ:EGRX)
07:14am, Tuesday, 21'st Apr 2020
Eagle Pharmaceuticals (NASDAQ:EGRX)‘s stock had its “hold” rating reiterated by analysts at Cantor Fitzgerald in a note issued to investors on Monday, TipRanks reports. They presently have a $46
35 Stocks Moving in Monday's Pre-Market Session
11:20am, Monday, 20'th Apr 2020
Gainers
American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT) shares rose 191.2% to $5.97 in pre-market trading after the company announced collaboration with Cytiva on COVID-...
Norges Bank Invests $14.91 Million in Eagle Pharmaceuticals Inc (NASDAQ:EGRX)
10:50am, Monday, 20'th Apr 2020
Norges Bank acquired a new stake in shares of Eagle Pharmaceuticals Inc (NASDAQ:EGRX) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commi
